The 2020 Healio Industry Breakthrough is ...
During this year’s ACG 2020 Virtual meeting, Healio hosted its annual Disruptive Innovators Award ceremony.
These awards stem from the disruption that Healio caused in gastroenterology by using a Peer Tested concept to deliver in print what physicians read online. Using analytics, data and social media, what is trending online is delivered to your mailbox. The Healio Disruptive Innovators represent the revolutionary mindset of Healio Gastroenterology.
From social media giants to health equity, these Healio Disruptive Innovators are the ultimate in Peer Tested with more than 1,000 of our readers and followers voting.
This award goes to a product that stands out as a major disruption to the practice of gastroenterology.
The awardee will have been acknowledged in practice guidelines and enthusiastically integrated into practice by practicing gastroenterologists.
This year’s winner is:
Since 2013, duodenoscopes have been the subject of much scrutiny and debate due to their implication in the spread of superviruses due to subpar decontamination.
According to Tyler Berzin, MD, and Mohammed Bilal, MD, between 2015 and July 2019 the FDA received reports of 1,115 duodenoscope incidents of patient infection, exposure, or device contamination, and 79 associated deaths.
In 2019, we saw approval of the first fully disposable duodenoscope from Boston Scientific. The Exalt Model D was tested in ERCPs and found to have a 96.7% completion rate and satisfaction rate of 9 out of 10.
As Raman Muthasamy, MD, said in his perspective on the FDA approval, “This device provides clinicians and health care facilities with a new option in combating the potential for patient-to-patient transmission of infections via duodenoscopes.”